| abstract |
A power source including two alkali metal/transition metal oxide cells discharged in parallel to power an implantable medical device is described. The first cell powers the medical device in both a device monitoring mode, for example in a cardiac defibrillator for monitoring the heart beat, and a device actuation mode for charging capacitors requiring high rate electrical pulse discharging. At such time as the first cell is discharged to a predetermined voltage limit, the first cell is disconnected from pulse discharge duty and only used for the device monitoring function. At that time, the second cell is utilized for the high rate electrical pulse discharging function. When the first cell reaches 100% efficiency or a present voltage limit, the second cell then takes over both device monitoring and device actuation functions. In that manner, a greater average discharge efficiency is realized from the two cells than is capable of being delivered from a single cell of similar chemistry. |